Genmab AS

Genmab AS Market Cap per Employee

The Market Cap per Employee of Genmab AS (GMAB) as of Nov 22, 2026 is 5.08 M USD. In the previous year, Market Cap per Employee was 5.08 M USD — a change of 0.00% (lower).

Market Cap per Employee

5.08 MUSD

YoY

0.00%

Last updated:

Market Cap per Employee of Genmab AS is 2025 5.08 M USD. Market Cap per Employee of Genmab AS was 2024 5.08 M USD. It decreases by 0.00% lower compared to the previous year.

The Genmab AS Market Cap per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market Cap per Employee
Date
Market Cap per Employee
Jan 1, 2018
5.08 M USD
Jan 1, 2019
5.08 M USD
Jan 1, 2020
5.08 M USD
Jan 1, 2021
5.08 M USD
Jan 1, 2022
5.08 M USD
Jan 1, 2023
5.08 M USD
Jan 1, 2024
5.08 M USD
Jan 1, 2025
5.08 M USD
The Genmab AS Market Cap per Employee history
YEARMarket Cap per EmployeeYoY
5.08 MUSD0.00%
5.08 MUSD0.00%
5.08 MUSD0.00%
5.08 MUSD0.00%
5.08 MUSD0.00%
5.08 MUSD0.00%
5.08 MUSD0.00%
5.08 MUSD0.00%
5.08 MUSD0.00%
5.08 MUSD0.00%
5.08 MUSD0.00%
5.08 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

Market Cap per Employee of Genmab AS is 5.08 M USD in 2025.

Market Cap per Employee of Genmab AS changed from 5.08 M USD to 5.08 M USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Market Cap per Employee Genmab AS since 2006 – with annual values, charts, and detailed analysis.

Market cap per employee shows the market value attributed to each employee. Technology companies typically have higher values due to intellectual capital.

Market Cap per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Market Cap per Employee's Genmab AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Genmab AS

All Key Metrics — Genmab AS